Rights and permissions
About this article
Cite this article
Percutaneous VEGF-2 gene therapy improves symptoms in inoperable refractory coronary artery disease. Inpharma Wkly. 1342, 12 (2002). https://doi.org/10.2165/00128413-200213420-00021
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200213420-00021